Loading...

Luff Enterprises Ltd.

LUFF.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.01
$0.005(100.00%)
Canadian Market opens in 7h 25m

Luff Enterprises Ltd. (LUFF.CN) Stock Competitors & Peer Comparison

See (LUFF.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LUFF.CNCA$0.01+100.00%4M-0.56-CA$0.02N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
CURA.TOCA$4.16+11.23%3.2B-9.45-CA$0.44N/A
BHC.TOCA$8.08-0.12%3B13.93CA$0.58N/A
GTII.CNCA$9.79+5.84%2.3B15.15CA$0.66N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
TRUL.CNCA$9.58+9.86%1.6B-11.97-CA$0.80N/A
CRON.TOCA$3.78+2.16%1.4B-126.00-CA$0.03N/A
TLRY.TOCA$9.75+3.17%1.1B-0.49-CA$20.09N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

LUFF.CN vs CURA.CN Comparison April 2026

LUFF.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LUFF.CN stands at 4M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, LUFF.CN is priced at CA$0.01, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LUFF.CN currently has a P/E ratio of -0.56, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, LUFF.CN's ROE is -0.32%, compared to CURA.CN's ROE of -0.24%. Regarding short-term risk, Volatility data is not available for a full comparison. LUFF.CN has daily volatility of N/A and CURA.CN has daily volatility of 10.82.Check CURA.CN's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions